Skip to main content
Log in

Effects of long-term supplementation of policosanol on blood cholesterol/glucose levels and 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in a rat model fed high cholesterol diets

  • Published:
Food Science and Biotechnology Aims and scope Submit manuscript

Abstract

Policosanol is a well-defined nutraceutical for the management of blood cholesterol levels. The present study examined (i) the effect of policosanol supplementation on blood cholesterol and glucose levels and (ii) changes in hepatic cholesterol biosynthesis using 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) activity in Wistar rats fed high cholesterol diets. The Wistar rats were assigned randomly to high-cholesterol diets (1.25% cholesterol) with or without policosanol (8.0 mg/kg body weight) for 6 weeks. Compared with the control group, dietary treatment with policosanol resulted in a significant decrease of blood cholesterol (p<0.01), blood glucose (p<0.01), triglyceride (p<0.001), and low density lipoprotein-cholesterol levels (p<0.01) and HMG-CoA reductase activity (p<0.001) in the liver. These results indicate that policosanol decreases blood cholesterol levels by suppressing cholesterol biosynthesis via decrease of HMG-CoA activity. Policosanol has the potential to be developed into an effective dietary strategy for both postprandial hyperglycemia and hypercholesterolemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2015 update: A report from the American heart association. Circulation 131: e29–e322 (2014)

    Article  Google Scholar 

  2. Lioyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation 121: 568–613 (2010)

    Google Scholar 

  3. Grundy SM. HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia. New Engl. J. Med. 319: 24–32 (1988)

    Article  CAS  Google Scholar 

  4. Endo A. The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res. 33: 1569–1582 (1992)

    CAS  Google Scholar 

  5. Hernandez F, Illnait J, Mas R, Castano G, Fernandez L, Gonzalez M, Cordovi N, Fernandez JC. Effects of policosanol on serum lipids and lipoproteins in healthy volunteers. Curr. Ther. Res. 51: 568–573 (1992)

    CAS  Google Scholar 

  6. Menedez R, Arruzarabala L, Mas R, Del Rio A, Amor A, Gonzalez RM, Carbajal D, Fraga V, Molina V, Illnait J. Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-casein diet. Brit. J. Nutr. 77: 923–932 (1997)

    Article  Google Scholar 

  7. Yanai H, Katsuyama H, Hamasaki H, Abe S, Tada N, Sako A. Effects of dietary fat intake on HDL metabolism. J. Clin. Med. Res. 7: 145–149 (2015)

    Article  Google Scholar 

  8. Banerjee S, Ghoshal S, Porter TD. Activation of AMP-kinase by policosanol requires peroxisomal metabolism. Lipids 46: 311–321 (2011)

    Article  CAS  Google Scholar 

  9. Singh DK, Poster TD. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase. J. Pharmacol. Exp. Ther. 318: 1020–1026 (2006)

    Article  CAS  Google Scholar 

  10. Beg ZH, Stonik JA, Brewer HB. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase: Regulation of enzymatic activity by phosphorylation and dephosphorylation. P. Natl. Acad. Sci. USA 75: 3678–3682 (1978)

    Article  CAS  Google Scholar 

  11. Menendez R, Amor AM, Conzalez RM, Fraga V, Mas R. Effect of policosanol on the hepatic cholesterol biosynthesis of normocholesterolemic rats. Biol. Res. 29: 253–257 (1996)

    CAS  Google Scholar 

  12. Oliaro-Bosso S, Calcio E, Mantegna S, Giraudo E, Meda C, Viola F, Cravotto G. Regulation of HMG-CoA reductase activity by policosanol and octacosadienol, a new synthetic analogue of octacosanol. Lipids 44: 907–916 (2009)

    Article  CAS  Google Scholar 

  13. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, Montminy M, Cantley LC. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310: 1642–1646 (2005)

    Article  CAS  Google Scholar 

  14. Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ. Res. 100: 328–341 (2007)

    Article  CAS  Google Scholar 

  15. Banerjee S, Ghoshal S, Porter DT. Phosphorylation of hepatic AMP-activated protein kinase and liver kinase B1 is increased after a single oral dose of green tea extract to mice. Nutr. Res. 32: 985–990 (2012)

    Article  CAS  Google Scholar 

  16. Xie Z, Dong R, Scholz D, Neumann M, Zou H. Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells. Circulation 117: 952–962 (2008)

    Article  CAS  Google Scholar 

  17. Zatara G, Bar-Tana J, Kalderon B, Suter M, Morad E, Samovski D, Neumann D, Hertz R. AMPK activation by long chain fatty acyl analogs. Biochem. Pharmacol. 76: 1263–1275 (2008)

    Article  CAS  Google Scholar 

  18. Renu A, Shrewsbury AM. 3-Hydroxy-3-methylglutaryl Coenzyme A reductase from rat liver. J. Biol. Chem. 251: 3815–3822 (1976)

    Google Scholar 

  19. Rodríguez-Echenique C, Mesa R, Más, R, Noa M, Menéndez R, González RM, Amor AM, Fraga V, Sotolongo V, Laguna A. Effect of policosanol chronically administered in male monkeys (Macaca arctoides). Food Chem. Toxicol. 32: 565–575 (1994)

    Article  Google Scholar 

  20. Castano G, Fernadez L, Mas R, Iiinait J, Mesa M, Fernandez JC. Comparison of the effects of Policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus. Clin. Drug Invest. 23: 639–650 (2003)

    Article  CAS  Google Scholar 

  21. Castaño G, Mas R, Fernández L, Illnait J, Gámez R, Alvarez E. Effects of Policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: A 6-month double-blind study. Int. J. Clin. Pharm. Res. 21: 43–57 (2001)

    Google Scholar 

  22. Gouni-Berthold I, Berthold HK. Policosanol: Clinical pharmacology and therapeutic significance of a new lipid-lowering agent. Am. Heart J. 143: 356–365 (2002)

    Article  CAS  Google Scholar 

  23. Heiner KB, Susanne U, Ralf D, Michael BD, Ioanna GB. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia. JAMA-J. Am. Med. Assoc. 295: 2262–2269 (2006)

    Article  Google Scholar 

  24. Pons P, Rodriguez M, Robaina C, Illnait J, Mas R, Fernandez L, Fernandez JC. Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolemia and tolerability to treatment. Int. J. Clin. Pharm. Res. 14: 27–33 (1994)

    CAS  Google Scholar 

  25. Chen JT, Wesley R, Shamburek RD, Pucino FC. GMeta-analysis of natural therapies for hyperlipidemia: Plant sterols and stanols versus policosanol. Pharmacotherapy 25: 171–183 (2005)

    Article  CAS  Google Scholar 

  26. Barrat E, Zaïr Y, Sirvent P, Chauveau P, Maudet C, Housez B, Derbord E, Lescuyer JF, Bard JM, Cazaubiel M, Peltier SL. Effect on LDL-cholesterol of a large dose of a dietary supplement with plant extracts in subjects with untreated moderate hypercholesterolaemia: A randomised, double-blind, placebo-controlled study. Eur. J. Nutr. 52: 1843–1852 (2013)

    Article  CAS  Google Scholar 

  27. Ogier N, Amiot MJ, Georgé S, Maillot M, Mallmann C, Maraninchi M, Morange S, Lescuyer JF, Peltier SL, Cardinault N. LDL-cholesterol-lowering effect of a dietary supplement with plant extracts in subjects with moderate hypercholesterolemia. Eur. J. Nutr. 52: 547–557 (2013)

    Article  CAS  Google Scholar 

  28. Li Q, Thomson AB, Clandinin MT. Cholesterol ester and free fatty acids are modulated by policosanol in CaCo-2 intestinal cell. J. Am. Coll. Nutr. 30: 201–209 (2011)

    Article  CAS  Google Scholar 

  29. Chi HN, Ka YL, Yu H, Zhen YC. Policosanol has no antioxidant activity in human low-density lipoprotein but increase excretion of bile acids in hamsters. J. Agr. Food Chem. 53: 6289–6293 (2005)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Young-In Kwon.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, JY., Choi, HY., Kang, YR. et al. Effects of long-term supplementation of policosanol on blood cholesterol/glucose levels and 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in a rat model fed high cholesterol diets. Food Sci Biotechnol 25, 899–904 (2016). https://doi.org/10.1007/s10068-016-0147-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10068-016-0147-y

Keywords

Navigation